Target Discovery for Host-Directed Antiviral Therapies: Application of Proteomics Approaches
Current epidemics, such as HIV or influenza, and the emergence of new threatening pathogens, such as the one causing the current coronavirus disease 2019 (COVID-19) pandemic, represent major global health challenges. While vaccination is an important part of the arsenal to counter the spread of vira...
Main Authors: | Merve Cakir, Kirsten Obernier, Antoine Forget, Nevan J. Krogan |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2021-10-01
|
Series: | mSystems |
Online Access: | https://journals.asm.org/doi/10.1128/mSystems.00388-21 |
Similar Items
-
SARS‐CoV‐2–host proteome interactions for antiviral drug discovery
by: Xiaonan Liu, et al.
Published: (2021-11-01) -
Repurposing Antifungals for Host-Directed Antiviral Therapy?
by: Sebastian Schloer, et al.
Published: (2022-02-01) -
Mapping genetic interactions in cancer: a road to rational combination therapies
by: Beril Tutuncuoglu, et al.
Published: (2019-10-01) -
Proteomic Approaches to Dissect Host SUMOylation during Innate Antiviral Immune Responses
by: Marie Lork, et al.
Published: (2021-03-01) -
Direct-Acting Antivirals and Host-Targeting Approaches against Enterovirus B Infections: Recent Advances
by: Chiara Tammaro, et al.
Published: (2023-01-01)